▶ 調査レポート

皮下免疫グロブリンの世界市場予測 2022年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Subcutaneous Immunoglobulins Market by Manufacturers, Countries, Type and Application, Forecast to 2022

GlobalInfoResearchが調査・発行した産業分析レポートです。皮下免疫グロブリンの世界市場予測 2022年:メーカー別、地域別、種類・用途別 / Global Subcutaneous Immunoglobulins Market by Manufacturers, Countries, Type and Application, Forecast to 2022 / B-GIR-031076資料のイメージです。• レポートコード:B-GIR-031076
• 出版社/出版日:GlobalInfoResearch / 2017年11月
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User¥375,840 (USD3,480)▷ お問い合わせ
  Corporate User¥505,440 (USD4,680)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、皮下免疫グロブリンの世界市場について調査・分析し、皮下免疫グロブリンの世界市場概観、メーカー動向、メーカー別皮下免疫グロブリンシェア、市場規模推移、市場規模予測、皮下免疫グロブリン種類別分析(純度10%、純度20%)、皮下免疫グロブリン用途別分析(原発性免疫不全、続発性免疫不全、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・皮下免疫グロブリンの市場概観
・皮下免疫グロブリンのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・皮下免疫グロブリンのメーカー別販売動向、市場シェア、市場集中度、競争動向
・皮下免疫グロブリンの世界市場規模
・皮下免疫グロブリンの北米市場分析(アメリカ、カナダ、メキシコ等)
・皮下免疫グロブリンのアメリカ市場規模
・皮下免疫グロブリンのカナダ市場規模
・皮下免疫グロブリンのメキシコ市場規模
・皮下免疫グロブリンのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・皮下免疫グロブリンのドイツ市場規模
・皮下免疫グロブリンのイギリス市場規模
・皮下免疫グロブリンのロシア市場規模
・皮下免疫グロブリンのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・皮下免疫グロブリンの日本市場規模
・皮下免疫グロブリンの中国市場規模
・皮下免疫グロブリンの韓国市場規模
・皮下免疫グロブリンのインド市場規模
・皮下免疫グロブリンの東南アジア市場規模
・皮下免疫グロブリンの南米・中東・アフリカ市場分析
・皮下免疫グロブリンの種類別分析/種類別市場規模(純度10%、純度20%)
・皮下免疫グロブリンの用途別分析/用途別市場規模(原発性免疫不全、続発性免疫不全、その他)
・皮下免疫グロブリンの市場予測(地域別予測、種類別予測、用途別予測)
・皮下免疫グロブリンの販売チャネル・代理店・貿易業者・ディーラー分析

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Scope of the Report:
This report focuses on the Subcutaneous Immunoglobulins in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Shire (Baxalta)
Grifols
CSL

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
10% Purity
20% Purity

Market Segment by Applications, can be divided into
Primary Immunodeficiency
Secondary Immunodeficiency
Others

There are 15 Chapters to deeply display the global Subcutaneous Immunoglobulins market.

Chapter 1, to describe Subcutaneous Immunoglobulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Subcutaneous Immunoglobulins, with sales, revenue, and price of Subcutaneous Immunoglobulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Subcutaneous Immunoglobulins, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Subcutaneous Immunoglobulins market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

レポート目次

Table of Contents

1 Market Overview
1.1 Subcutaneous Immunoglobulins Introduction
1.2 Market Analysis by Type
1.2.1 10% Purity
1.2.2 20% Purity
1.3 Market Analysis by Applications
1.3.1 Primary Immunodeficiency
1.3.2 Secondary Immunodeficiency
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Business Overview
2.1.2 Subcutaneous Immunoglobulins Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Subcutaneous Immunoglobulins Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
2.3.1 Business Overview
2.3.2 Subcutaneous Immunoglobulins Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Subcutaneous Immunoglobulins Market Competition, by Manufacturer
3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer
3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share
3.3.2 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share
3.4 Market Competition Trend
4 Global Subcutaneous Immunoglobulins Market Analysis by Regions
4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions
4.1.1 Global Subcutaneous Immunoglobulins Sales by Regions (2012-2017)
4.1.2 Global Subcutaneous Immunoglobulins Revenue by Regions (2012-2017)
4.2 North America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.3 Europe Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.5 South America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5 North America Subcutaneous Immunoglobulins by Countries
5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
5.1.1 North America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
5.1.2 North America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
5.2 USA Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5.3 Canada Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5.4 Mexico Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6 Europe Subcutaneous Immunoglobulins by Countries
6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
6.1.2 Europe Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
6.2 Germany Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.3 UK Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.4 France Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.5 Russia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.6 Italy Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7 Asia-Pacific Subcutaneous Immunoglobulins by Countries
7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
7.2 China Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.3 Japan Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.4 Korea Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.5 India Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.6 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8 South America Subcutaneous Immunoglobulins by Countries
8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
8.1.1 South America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
8.1.2 South America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
8.2 Brazil Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8.3 Argentina Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8.4 Columbia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9 Middle East and Africa Subcutaneous Immunoglobulins by Countries
9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
9.2 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.3 UAE Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.4 Egypt Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.5 Nigeria Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.6 South Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
10 Global Subcutaneous Immunoglobulins Market Segment by Type
10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2012-2017)
10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2012-2017)
10.2 10% Purity Sales Growth and Price
10.2.1 Global 10% Purity Sales Growth (2012-2017)
10.2.2 Global 10% Purity Price (2012-2017)
10.3 20% Purity Sales Growth and Price
10.3.1 Global 20% Purity Sales Growth (2012-2017)
10.3.2 Global 20% Purity Price (2012-2017)
11 Global Subcutaneous Immunoglobulins Market Segment by Application
11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
11.2 Primary Immunodeficiency Sales Growth (2012-2017)
11.3 Secondary Immunodeficiency Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)
12 Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2017-2022)
12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2017-2022)
12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2017-2022)
12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Subcutaneous Immunoglobulins Picture
Table Product Specifications of Subcutaneous Immunoglobulins
Figure Global Sales Market Share of Subcutaneous Immunoglobulins by Types in 2016
Table Subcutaneous Immunoglobulins Types for Major Manufacturers
Figure 10% Purity Picture
Figure 20% Purity Picture
Table Subcutaneous Immunoglobulins Sales Market Share by Applications in 2016
Figure Primary Immunodeficiency Picture
Figure Secondary Immunodeficiency Picture
Figure Others Picture
Figure USA Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure France Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure UK Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure China Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure India Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Subcutaneous Immunoglobulins Revenue (Value) and Growth Rate (2012-2022)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Subcutaneous Immunoglobulins Type and Applications
Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Subcutaneous Immunoglobulins Type and Applications
Table Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Subcutaneous Immunoglobulins Type and Applications
Table CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Subcutaneous Immunoglobulins Sales by Manufacturer (2016-2017)
Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2016
Figure Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer in 2017
Table Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2016-2017)
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2016
Figure Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturer in 2017
Figure Global Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Global Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales by Regions (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales Market Share by Regions (2012-2017)
Table Global Subcutaneous Immunoglobulins Revenue by Regions (2012-2017)
Table Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2012
Table Global Subcutaneous Immunoglobulins Revenue Market Share by Regions in 2016
Figure North America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure South America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure North America Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table North America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
Table North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2012
Figure North America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2016
Table North America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
Table North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2012
Figure North America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure USA Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Canada Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Mexico Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table Europe Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
Table Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Table Europe Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
Table Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2012
Table Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Germany Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure UK Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure France Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Russia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Italy Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Asia-Pacific Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
Table Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure China Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Japan Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Korea Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure India Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Southeast Asia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure South America Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table South America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
Table South America Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure South America Subcutaneous Immunoglobulins Sales Market Share by Countries in 2016
Table South America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
Table South America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2012
Figure South America Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Brazil Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Argentina Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Columbia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue and Growth (2012-2017)
Table Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
Table Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries in 2016
Table Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
Table Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2012
Figure Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure UAE Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Egypt Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure Nigeria Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Figure South Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales by Type (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales Share by Type (2012-2017)
Table Global Subcutaneous Immunoglobulins Revenue by Type (2012-2017)
Table Global Subcutaneous Immunoglobulins Revenue Share by Type (2012-2017)
Figure Global 10% Purity Sales Growth (2012-2017)
Figure Global 10% Purity Price (2012-2017)
Figure Global 20% Purity Sales Growth (2012-2017)
Figure Global 20% Purity Price (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales by Application (2012-2017)
Table Global Subcutaneous Immunoglobulins Sales Share by Application (2012-2017)
Figure Global Primary Immunodeficiency Sales Growth (2012-2017)
Figure Global Secondary Immunodeficiency Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2017 -2022)
Table Global Subcutaneous Immunoglobulins Sales Forecast by Regions (2017-2022)
Table Global Subcutaneous Immunoglobulins Market Share Forecast by Regions (2017-2022)
Figure North America Sales Subcutaneous Immunoglobulins Market Forecast (2017-2022)
Figure Europe Sales Subcutaneous Immunoglobulins Market Forecast (2017-2022)
Figure Asia-Pacific Sales Subcutaneous Immunoglobulins Market Forecast (2017-2022)
Figure South America Sales Subcutaneous Immunoglobulins Market Forecast (2017-2022)
Figure Middle East and Africa Sales Subcutaneous Immunoglobulins Market Forecast (2017-2022)
Table Global Subcutaneous Immunoglobulins Sales Forecast by Type (2017-2022)
Table Global Subcutaneous Immunoglobulins Market Share Forecast by Type (2017-2022)
Table Global Subcutaneous Immunoglobulins Sales Forecast by Application (2017-2022)
Table Global Subcutaneous Immunoglobulins Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List